A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects

Clinical trial NCT00504439 · COMPLETED

Trial details

NCT number: NCT00504439
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2007-06-04
Primary completion: 2007-09-06
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.